Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P57
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValue
2025-2.18%
2024-2.21%
20230.49%
202231.36%
2021-55.75%
2020-58.79%
2019-673.14%
20180.00%